Vieira C - Search Results

1

The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data.

Borges A, Pereira F, Redondo P, Antunes L, Vieira C, Antunes P, Bento MJ, Sousa S, Lopes JM, Rocha-Gonçalves F, de Sousa JA, Pereira DS, Borges M. Borges A, et al. Among authors: vieira c. Health Econ Rev. 2021 Sep 10;11(1):33. doi: 10.1186/s13561-021-00332-0. Health Econ Rev. 2021. PMID: 34505956 Free PMC article.

2

Bevacizumab in the treatment of metastatic breast cancer: three case reports.

Ferreira A, Vieira C, Rodrigues A, Pereira D, Rodrigues H, Dávila C, Bento S. Ferreira A, et al. Among authors: vieira c. Curr Opin Oncol. 2011 Apr;23 Suppl:S11-9. doi: 10.1097/01.cco.0000397418.52374.28. Curr Opin Oncol. 2011. PMID: 21490480

3

The history of cancer pain and bone-targeted agents: 10 most commonly asked questions.

Vieira CMP, Fragoso M, Ferreira M, Pereira FF, Pereira D, Medeiros R. Vieira CMP, et al. Cancer Manag Res. 2018 Dec 18;11:37-46. doi: 10.2147/CMAR.S174731. eCollection 2019. Cancer Manag Res. 2018. PMID: 30588109 Free PMC article. Review.

4

Pain polymorphisms and opioids: An evidence based review.

Vieira CMP, Fragoso RM, Pereira D, Medeiros R. Vieira CMP, et al. Mol Med Rep. 2019 Mar;19(3):1423-1434. doi: 10.3892/mmr.2018.9792. Epub 2018 Dec 24. Mol Med Rep. 2019. PMID: 30592275 Free PMC article.

5

Pain prevalence and treatment in patients with metastatic bone disease.

Vieira C, Fragoso M, Pereira D, Medeiros R. Vieira C, et al. Oncol Lett. 2019 Mar;17(3):3362-3370. doi: 10.3892/ol.2019.10013. Epub 2019 Feb 4. Oncol Lett. 2019. PMID: 30867771 Free PMC article.

6

A 10-year review of primary major salivary gland cancers.

Cruz A, Magalhães H, Pereira FF, Dinis J, Vieira C. Cruz A, et al. Among authors: vieira c. Ecancermedicalscience. 2020 Jun 12;14:1055. doi: 10.3332/ecancer.2020.1055. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32582370 Free PMC article.

7

Genetic Polymorphisms as Predictors of Survival in Breast Cancer: Future Lessons in Historical Data.

Leitão M, Lopes S, Pereira D, Medeiros R, Vieira C. Leitão M, et al. Among authors: vieira c. Cureus. 2022 Jan 19;14(1):e21410. doi: 10.7759/cureus.21410. eCollection 2022 Jan. Cureus. 2022. PMID: 35198317 Free PMC article.

8

Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer.

Vieira C, Borges A, Pereira FF, Antunes P, Redondo P, Antunes L, Lopes JM, Gonçalves FR, Borges M, Bento MJ. Vieira C, et al. J Immunother Precis Oncol. 2022 Dec 13;6(1):1-9. doi: 10.36401/JIPO-22-12. eCollection 2023 Feb. J Immunother Precis Oncol. 2022. PMID: 36751658 Free PMC article.

9

Systemic treatment for hormone receptor-positive/HER2-negative advanced/metastatic breast cancer: A review of European real-world evidence studies.

Vieira C, Piperis MN, Sagkriotis A, Cottu P. Vieira C, et al. Crit Rev Oncol Hematol. 2022 Dec;180:103866. doi: 10.1016/j.critrevonc.2022.103866. Epub 2022 Nov 3. Crit Rev Oncol Hematol. 2022. PMID: 36336168 Free article. Review.

10

Esthesioneuroblastoma: 38 years of experience in an oncological center.

Costa SPF, Rocha E, Rodrigues J, Soares A, Moreira D, Vieira C. Costa SPF, et al. Among authors: vieira c. Rep Pract Oncol Radiother. 2024 Jun 6;29(2):197-203. doi: 10.5603/rpor.99705. eCollection 2024. Rep Pract Oncol Radiother. 2024. PMID: 39143973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,120 results

Search Page

Filters